biology

Lifileucel

Lifileucel is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Lifileucel rather than just read about it. In short: Lifileucel, sold under the brand name Amtagvi, is an adoptive T cell therapy used for the treatment of melanoma. Specifically, lifileucel is a tumor-derived T cell immunotherapy composed of a recipient's own T cells (autologous).

Key takeaways

Lifileucel belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Lifileucel to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Lifileucel from memory before moving on to harder problems.

Reference excerpt

Lifileucel, sold under the brand name Amtagvi, is an adoptive T cell therapy used for the treatment of melanoma. Specifically, lifileucel is a tumor-derived T cell immunotherapy composed of a recipient's own T cells (autologous). A portion of the recipient's tumor tissue is removed during a surgical procedure prior to treatment. The recipient's T cells (the tumor-infiltrating lymphocytes) are separated from the tumor tissue, multiplied and then infused into the recipient in a single dose. T cells are a type of cell that helps the immune system fight cancer and infections. The most common adverse reactions include chills, fever, fatigue, tachycardia (abnormally fast heart rate), diarrhea, febrile neutropenia (fever associated with a low level of certain white blood cells), edema (swelling due to buildup of fluid in body tissues), rash, hypotension, hair loss, infection, hypoxia (abnormally low oxygen levels in the body) and shortness of breath. Lifileucel is the first tumor-derived T cell immunotherapy approved by the US Food and Drug Administration. It was approved for medical use in the United States in February 2024.

Medical uses Lifileucel is indicated for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (spread to other parts of the body) melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor.

Side effects The most common adverse reactions include chills, fever, fatigue, tachycardia (abnormally fast heart rate), diarrhea, febrile neutropenia (fever associated with a low level of certain white blood cells), edema (swelling due to buildup of fluid in body tissues), rash, hypotension, hair loss, infection, hypoxia (abnormally low oxygen levels in the body) and feeling short of breath. People treated with lifileucel may exhibit prolonged severe low blood count, severe infection, cardiac disorder, or develop worsened respiratory or renal function or have fatal treatment-related complications. A boxed warning is included in the prescribing informationl containing information about these risks.

History The safety and effectiveness of lifileucel was evaluated in a global, multi-center, multi-cohort, clinical study including adult participants with unresectable or metastatic melanoma who had previously been treated with at least one systemic therapy, including a PD-1 blocking antibody, and if positive for the BRAF V600 mutation, a BRAF inhibitor or BRAF inhibitor with an MEK inhibitor. Effectiveness was measured via the objective response rate to treatment and duration of response (measured from the date of confirmed initial objective response to the date of progression, death from any cause, starting a new anti-cancer treatment or discontinuation from follow-up, whichever came first). The US Food and Drug Administration (FDA) approved Lifileucel through the accelerated approval pathway and granted the application orphan drug, regenerative medicine advanced therapy, fast track, and priority review designations under the brand name Amtagvi to Iovance Biotherapeutics.

Society and culture

Legal status Lifileucel was approved for medical use in the United States in February 2024.

Names Lifileucel is the international nonproprietary name. Lifileucel is sold under the brand name Amtagvi.

Research The clinical trials for lifileucel in melanoma include two phases. Phase II (178 participants) demonstrated the therapy's efficacy and durable response in participants with unresectable or metastatic melanoma who had failed PD-1 blockers and BRAF inhibitors. However, adverse effects were statistically significant. Phase III (670 participants) aims to compare lifileucel combined with pembrolizumab for advanced melanoma stages (IIIC, IIID, or IV). Results are expected by 2028 and full completion by 2030.

References

This article incorporates public domain material from US Food and Drug Administration. United States Department of Health and Human Services.

External links "Lifileucel". NCI Thesaurus.

Worked examples

Example 1 — a first encounter with Lifileucel

Start with the simplest possible case. Write down what Lifileucel claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Lifileucel before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Lifileucel ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Lifileucel

In research: Lifileucel appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Lifileucel in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Lifileucel is common in secondary-school and first-year university syllabi. It links to neighbouring topics Cancer treatments, Cell therapies, Orphan drugs, so understanding it makes those chapters shorter.
In everyday life: Look for Lifileucel outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Lifileucel” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Lifileucel in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Lifileucel means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Lifileucel out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Lifileucel in simple terms?

Why does Lifileucel matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Lifileucel?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Lifileucel.